Glenmark Pharma President and Chief Medical Officer Fred Grossman said atopic dermatitis can have a severe impact on quality of life and th...

The S&P BSE Sensex plunged over 200 points in trade on Friday tracking muted trend seen in other Asian markets. The fall in the index was l...

Indian markets are expected to trade in a range. Here is a list of fourteen stocks which are likely to remain in focus today.

Glenmark Pharmaceuticals has completed the clinical phase I studies for its novel monoclonal antibody 'GBR 830' for treating autoimmune dis...

Pain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing ...

The Nifty was at 7,728.70, up 13.90 points or 0.18 per cent. It touched intraday high of 7,731.45 and a low of 7,708.90 in trade today.

Indian markets are expected to trade in a range. Here is a list of fifteen stocks which are likely to be in focus today.

Glenmark Pharmaceuticals S.A., a wholly owned Swiss subsidiary of Glenmark Pharmaceuticals, said GBR 830 is entering human trials.

Glenmark Pharmaceuticals opened a new manufacturing facility in Switzerland for supply of clinical trial material.

Glenmark Pharmaceuticals initiates studies to develop a new molecule 'GBR 830', which could treat diseases like Arthritis (RA) and bowel di...